Selected research
Industry Research
Proton Therapy System for Cancer Industry Research Report 2026
Market perspective
The global Proton Therapy System for Cancer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Proton Therapy System for Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Proton Therapy System for Cancer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Proton Therapy System for Cancer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Proton Therapy System for Cancer include IBA, Hitachi, Ltd., ITEL Telecomunicazioni, Mevion Medical Systems, Mitsubishi Electric, ProNova Solutions, ProTom, Provision Healthcare and Sumitomo Heavy Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Proton Therapy System for Cancer market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Proton Therapy System for Cancer Market by Company
IBA
Hitachi, Ltd.
ITEL Telecomunicazioni
Mevion Medical Systems
Mitsubishi Electric
ProNova Solutions
ProTom
Provision Healthcare
Sumitomo Heavy Industries
Varian Medical Systems
Proton Therapy System for Cancer Segment by Type
Compact Proton Therapy System
Regular Proton Therapy System
Proton Therapy System for Cancer Segment by Application
Hospitals
Research and Treatment Center
Other
Proton Therapy System for Cancer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Proton Therapy System for Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Proton Therapy System for Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Proton Therapy System for Cancer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Proton Therapy System for Cancer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Proton Therapy System for Cancer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Proton Therapy System for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Compact Proton Therapy System
- Regular Proton Therapy System
Applications
- Hospitals
- Research and Treatment Center
- Other
Companies covered
- IBA
- Hitachi, Ltd.
- ITEL Telecomunicazioni
- Mevion Medical Systems
- Mitsubishi Electric
- ProNova Solutions
- ProTom
- Provision Healthcare
- Sumitomo Heavy Industries
- Varian Medical Systems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Proton Therapy System for Cancer Market Size (2021-2032)
- 2.2.2 Global Proton Therapy System for Cancer Sales (2021-2032)
- 2.2.3 Global Proton Therapy System for Cancer Market Average Price (2021-2032)
- 2.3 Proton Therapy System for Cancer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Compact Proton Therapy System
- 2.3.3 Regular Proton Therapy System
- 2.4 Proton Therapy System for Cancer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Research and Treatment Center
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Proton Therapy System for Cancer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Proton Therapy System for Cancer Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Proton Therapy System for Cancer Revenue of Manufacturers (2021-2026)
- 3.4 Global Proton Therapy System for Cancer Average Price by Manufacturers (2021-2026)
- 3.5 Global Proton Therapy System for Cancer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Proton Therapy System for Cancer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Proton Therapy System for Cancer, Product Type & Application
- 3.8 Global Manufacturers of Proton Therapy System for Cancer, Established Date
- 3.9 Global Proton Therapy System for Cancer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 IBA
- 4.1.1 IBA Company Information
- 4.1.2 IBA Business Overview
- 4.1.3 IBA Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 IBA Proton Therapy System for Cancer Product Portfolio
- 4.1.5 IBA Recent Developments
- 4.2 Hitachi, Ltd.
- 4.2.1 Hitachi, Ltd. Company Information
- 4.2.2 Hitachi, Ltd. Business Overview
- 4.2.3 Hitachi, Ltd. Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hitachi, Ltd. Proton Therapy System for Cancer Product Portfolio
- 4.2.5 Hitachi, Ltd. Recent Developments
- 4.3 ITEL Telecomunicazioni
- 4.3.1 ITEL Telecomunicazioni Company Information
- 4.3.2 ITEL Telecomunicazioni Business Overview
- 4.3.3 ITEL Telecomunicazioni Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ITEL Telecomunicazioni Proton Therapy System for Cancer Product Portfolio
- 4.3.5 ITEL Telecomunicazioni Recent Developments
- 4.4 Mevion Medical Systems
- 4.4.1 Mevion Medical Systems Company Information
- 4.4.2 Mevion Medical Systems Business Overview
- 4.4.3 Mevion Medical Systems Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mevion Medical Systems Proton Therapy System for Cancer Product Portfolio
- 4.4.5 Mevion Medical Systems Recent Developments
- 4.5 Mitsubishi Electric
- 4.5.1 Mitsubishi Electric Company Information
- 4.5.2 Mitsubishi Electric Business Overview
- 4.5.3 Mitsubishi Electric Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mitsubishi Electric Proton Therapy System for Cancer Product Portfolio
- 4.5.5 Mitsubishi Electric Recent Developments
- 4.6 ProNova Solutions
- 4.6.1 ProNova Solutions Company Information
- 4.6.2 ProNova Solutions Business Overview
- 4.6.3 ProNova Solutions Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ProNova Solutions Proton Therapy System for Cancer Product Portfolio
- 4.6.5 ProNova Solutions Recent Developments
- 4.7 ProTom
- 4.7.1 ProTom Company Information
- 4.7.2 ProTom Business Overview
- 4.7.3 ProTom Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ProTom Proton Therapy System for Cancer Product Portfolio
- 4.7.5 ProTom Recent Developments
- 4.8 Provision Healthcare
- 4.8.1 Provision Healthcare Company Information
- 4.8.2 Provision Healthcare Business Overview
- 4.8.3 Provision Healthcare Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Provision Healthcare Proton Therapy System for Cancer Product Portfolio
- 4.8.5 Provision Healthcare Recent Developments
- 4.9 Sumitomo Heavy Industries
- 4.9.1 Sumitomo Heavy Industries Company Information
- 4.9.2 Sumitomo Heavy Industries Business Overview
- 4.9.3 Sumitomo Heavy Industries Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sumitomo Heavy Industries Proton Therapy System for Cancer Product Portfolio
- 4.9.5 Sumitomo Heavy Industries Recent Developments
- 4.10 Varian Medical Systems
- 4.10.1 Varian Medical Systems Company Information
- 4.10.2 Varian Medical Systems Business Overview
- 4.10.3 Varian Medical Systems Proton Therapy System for Cancer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Varian Medical Systems Proton Therapy System for Cancer Product Portfolio
- 4.10.5 Varian Medical Systems Recent Developments
5 Global Proton Therapy System for Cancer Market Scenario by Region
- 5.1 Global Proton Therapy System for Cancer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Proton Therapy System for Cancer Sales by Region: 2021-2032
- 5.2.1 Global Proton Therapy System for Cancer Sales by Region: 2021-2026
- 5.2.2 Global Proton Therapy System for Cancer Sales by Region: 2027-2032
- 5.3 Global Proton Therapy System for Cancer Revenue by Region: 2021-2032
- 5.3.1 Global Proton Therapy System for Cancer Revenue by Region: 2021-2026
- 5.3.2 Global Proton Therapy System for Cancer Revenue by Region: 2027-2032
- 5.4 North America Proton Therapy System for Cancer Market Facts & Figures by Country
- 5.4.1 North America Proton Therapy System for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Proton Therapy System for Cancer Sales by Country (2021-2032)
- 5.4.3 North America Proton Therapy System for Cancer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Proton Therapy System for Cancer Market Facts & Figures by Country
- 5.5.1 Europe Proton Therapy System for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Proton Therapy System for Cancer Sales by Country (2021-2032)
- 5.5.3 Europe Proton Therapy System for Cancer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Proton Therapy System for Cancer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Proton Therapy System for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Proton Therapy System for Cancer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Proton Therapy System for Cancer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Proton Therapy System for Cancer Market Facts & Figures by Country
- 5.7.1 South America Proton Therapy System for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Proton Therapy System for Cancer Sales by Country (2021-2032)
- 5.7.3 South America Proton Therapy System for Cancer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Proton Therapy System for Cancer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Proton Therapy System for Cancer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Proton Therapy System for Cancer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Proton Therapy System for Cancer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Proton Therapy System for Cancer Sales by Type (2021-2032)
- 6.1.1 Global Proton Therapy System for Cancer Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Proton Therapy System for Cancer Sales Market Share by Type (2021-2032)
- 6.2 Global Proton Therapy System for Cancer Revenue by Type (2021-2032)
- 6.2.1 Global Proton Therapy System for Cancer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Proton Therapy System for Cancer Revenue Market Share by Type (2021-2032)
- 6.3 Global Proton Therapy System for Cancer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Proton Therapy System for Cancer Sales by Application (2021-2032)
- 7.1.1 Global Proton Therapy System for Cancer Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Proton Therapy System for Cancer Sales Market Share by Application (2021-2032)
- 7.2 Global Proton Therapy System for Cancer Revenue by Application (2021-2032)
- 7.2.1 Global Proton Therapy System for Cancer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Proton Therapy System for Cancer Revenue Market Share by Application (2021-2032)
- 7.3 Global Proton Therapy System for Cancer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Proton Therapy System for Cancer Value Chain Analysis
- 8.1.1 Proton Therapy System for Cancer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Proton Therapy System for Cancer Production Mode & Process
- 8.2 Proton Therapy System for Cancer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Proton Therapy System for Cancer Distributors
- 8.2.3 Proton Therapy System for Cancer Customers
9 Global Proton Therapy System for Cancer Analyzing Market Dynamics
- 9.1 Proton Therapy System for Cancer Industry Trends
- 9.2 Proton Therapy System for Cancer Industry Drivers
- 9.3 Proton Therapy System for Cancer Industry Opportunities and Challenges
- 9.4 Proton Therapy System for Cancer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst